Table 4 Adverse reactions in both groups of patients (n = 82)
Adverse event (<30 days) | HIPEC (n = 37) | Non-HIPEC (n = 45) | P |
|---|---|---|---|
Nausea/vomiting, n (%) | 13 (35.1) | 15 (33.3) | 0.864 |
Diarrhea, n (%) | 17 (45.9) | 22 (48.9) | 0.791 |
Fever, n (%) | 12 (32.4) | 10 (22.2) | 0.299 |
Neutrophil count decreased, n (%) | 12 (32.4) | 4 (8.9) | 0.007 |
Aminotransferase increased, n (%) | 6 (16.2) | 3 (6.7) | 0.287 |
Creatinine increased, n (%) | 9 (24.3) | 6 (13.3) | 0.200 |
Peripheral neurotoxicity, n (%) | 9 (24.3) | 2 (4.4) | 0.019 |